Thursday, December 29, 2016
NIAID Reflects on a Productive 2016
As 2017 approaches, a new slideshow highlights notable scientific accomplishments made by NIAID laboratories and NIAID-funded scientists during fiscal year 2016. Among many advances, NIAID research drove progress toward development of vaccines and treatments for HIV, flu, Zika, and other infectious diseases of global importance. Researchers also made discoveries yielding new insights into food allergy prevention, autoimmune diseases, and drug-resistant infections.
Selected NIAID Research Advances of 2016